Synopsis
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
Jai Radhe Sales is your partner for all your sourcing needs.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)
USFDA APPLICATION NUMBER - 200656
Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
Regulatory FDF Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
20 Aug 2024
Reply
15 May 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
36
PharmaCompass offers a list of Sodium Glycerophosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier.
PharmaCompass also assists you with knowing the Sodium Glycerophosphate API Price utilized in the formulation of products. Sodium Glycerophosphate API Price is not always fixed or binding as the Sodium Glycerophosphate Price is obtained through a variety of data sources. The Sodium Glycerophosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alpha-Glycerophosphoric Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alpha-Glycerophosphoric Acid, including repackagers and relabelers. The FDA regulates Alpha-Glycerophosphoric Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alpha-Glycerophosphoric Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alpha-Glycerophosphoric Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alpha-Glycerophosphoric Acid supplier is an individual or a company that provides Alpha-Glycerophosphoric Acid active pharmaceutical ingredient (API) or Alpha-Glycerophosphoric Acid finished formulations upon request. The Alpha-Glycerophosphoric Acid suppliers may include Alpha-Glycerophosphoric Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Alpha-Glycerophosphoric Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alpha-Glycerophosphoric Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Alpha-Glycerophosphoric Acid active pharmaceutical ingredient (API) in detail. Different forms of Alpha-Glycerophosphoric Acid DMFs exist exist since differing nations have different regulations, such as Alpha-Glycerophosphoric Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alpha-Glycerophosphoric Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Alpha-Glycerophosphoric Acid USDMF includes data on Alpha-Glycerophosphoric Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alpha-Glycerophosphoric Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alpha-Glycerophosphoric Acid suppliers with USDMF on PharmaCompass.
A Alpha-Glycerophosphoric Acid CEP of the European Pharmacopoeia monograph is often referred to as a Alpha-Glycerophosphoric Acid Certificate of Suitability (COS). The purpose of a Alpha-Glycerophosphoric Acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Alpha-Glycerophosphoric Acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Alpha-Glycerophosphoric Acid to their clients by showing that a Alpha-Glycerophosphoric Acid CEP has been issued for it. The manufacturer submits a Alpha-Glycerophosphoric Acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a Alpha-Glycerophosphoric Acid CEP holder for the record. Additionally, the data presented in the Alpha-Glycerophosphoric Acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Alpha-Glycerophosphoric Acid DMF.
A Alpha-Glycerophosphoric Acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Alpha-Glycerophosphoric Acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Alpha-Glycerophosphoric Acid suppliers with CEP (COS) on PharmaCompass.
A Alpha-Glycerophosphoric Acid written confirmation (Alpha-Glycerophosphoric Acid WC) is an official document issued by a regulatory agency to a Alpha-Glycerophosphoric Acid manufacturer, verifying that the manufacturing facility of a Alpha-Glycerophosphoric Acid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Alpha-Glycerophosphoric Acid APIs or Alpha-Glycerophosphoric Acid finished pharmaceutical products to another nation, regulatory agencies frequently require a Alpha-Glycerophosphoric Acid WC (written confirmation) as part of the regulatory process.
click here to find a list of Alpha-Glycerophosphoric Acid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alpha-Glycerophosphoric Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alpha-Glycerophosphoric Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alpha-Glycerophosphoric Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alpha-Glycerophosphoric Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alpha-Glycerophosphoric Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alpha-Glycerophosphoric Acid suppliers with NDC on PharmaCompass.
Alpha-Glycerophosphoric Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alpha-Glycerophosphoric Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alpha-Glycerophosphoric Acid GMP manufacturer or Alpha-Glycerophosphoric Acid GMP API supplier for your needs.
A Alpha-Glycerophosphoric Acid CoA (Certificate of Analysis) is a formal document that attests to Alpha-Glycerophosphoric Acid's compliance with Alpha-Glycerophosphoric Acid specifications and serves as a tool for batch-level quality control.
Alpha-Glycerophosphoric Acid CoA mostly includes findings from lab analyses of a specific batch. For each Alpha-Glycerophosphoric Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alpha-Glycerophosphoric Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Alpha-Glycerophosphoric Acid EP), Alpha-Glycerophosphoric Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alpha-Glycerophosphoric Acid USP).
Comment (7)
